DrugNews.net
Speak with a patient advocate.
Understand your options.
Case Evaluation

Risperdal Settlement Update

Following reports that the popular antipsychotic drug Risperdal can cause abnormal breast growth in children and adult males, hundreds of patients and families have come forward to seek compensation from the manufacturer, Johnson & Johnson.

So far, nearly 500 lawsuits have been filed and J&J has begun settling cases before they reach trial. The latest Risperdal settlement update indicates thousands more cases could be filed in the coming year, leading to a widespread settlement.

J&J faces liability for allegations that they fraudulently marketed Risperdal for uses not approved by the FDA, that the product was defective and dangerous, and that they failed to properly warn consumers.

Although Risperdal was designed to treat schizophrenia, bipolar disorder and autism, J&J reportedly encouraged doctors to prescribe it for the unapproved treatment of ADHD in children, resulting in hundreds of thousands of prescriptions. The company has been fined over $1.2 billion for this alleged false marketing.

In 2012, the first Risperdal lawsuit was scheduled to begin trial for a 21-year-old male who developed breasts so large after taking the drug that he required surgery to remove them. In the latest Risperdal settlement update, J&J has settled this case and several since for unpublicized amounts in order to avoid damaging public trials.

If you or your child developed abnormal breast growth or diabetes after taking Risperdal, contact us today for the latest Risperdal settlement update or to speak directly with a lawyer. You may be entitled to substantial compensation.

Risperdal has been shown to cause gynecomastia, a condition linked to elevated prolactin hormones which can lead to abnormal breast development and milk production in children and adult males. The hormone can also delay male sexual development in young boys.

This year, researchers also discovered that drugs like Risperdal may cause children to develop type 2 diabetes at three times the normal rate. This condition can cause a lifetime of hearing, vision, skin and blood pressure problems.

Studies have shown that as many as 87% of children taking Risperdal can have elevated prolactin hormones, increasing the risk of gynecomastia. Approximately 2.3% of children may develop abnormal breasts and almost 1% can produce breast milk.

In addition to the traumatic emotional effects that abnormal breast growth can have on children and males, the condition is permanent and often requires painful mastectomy surgery to correct.

So far, the FDA has not ordered a recall of Risperdal or required that new warnings be posted on the drug. However, those affected can seek compensation from the manufacturer for all of their damages.

Lawyers have already helped hundreds of families affected by Risperdal side effects, and are available to discuss your case today. They can let you know if you qualify for a claim and how much time is left to take action. They can also give a Risperdal settlement update and handle your case at no cost unless you recover.

However, it is important to choose a lawyer with significant experience handling this type of complex case against large drug companies.

DrugNews only recommends lawyers and law firms that specialize in defective drug litigation and have already handled Risperdal lawsuits.

For more information on the warnings, research, side effects and legal action related to Risperdal, or to speak directly with a lawyer, contact us today. We are available 24 hours a day to help.